353 articles in this topic
New research reveals pulsed electromagnetic field therapy selectively enhances ATP-linked mitochondrial respiration, pointing to a specific cellular energy mechanism.
Longevity experts endorse short CGM trials for non-diabetics, but RCT evidence remains thin. Here's what the data actually shows.
A steroid hormone activates receptor GPR56 to block ferroptosis, a form of iron-driven cell death linked to liver disease.
The FDA reportedly approved Eli Lilly's orforglipron, a daily oral GLP-1 receptor agonist for obesity, marking a potential shift from injectable weight-loss drugs.
A large Japanese cohort study shows polygenic risk scores predict T2D onset, yet exercise and metabolic health blunt even high genetic risk.
Longevity experts endorse CGMs for metabolic optimization, but RCT evidence in non-diabetics is still thin.
FTO demethylase in AgRP neurons alters Kif1a splicing to boost neuropeptide release, promoting weight gain in mice.
New research argues shared household metabolic factors — not just intrauterine exposure — drive MASLD risk in offspring.
New research reveals oxytocin signals fat cells to release lipids for milk, reshaping our understanding of lactation biology.
Top longevity doctors endorse CGMs for healthy adults, but evidence is mixed. Here's what the 2026 device reviews reveal.
New composite biomarker combining inflammation, nutrition, and immunity markers shows promise for cardiovascular risk assessment.
New research reveals how RAP1A protein regulates liver blood vessel function and may influence fibrosis progression in chronic liver disease.
